Oral agents for type 2 diabetes reduce HbA1c, are weight neutral.
D000218:Adamantane / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000284:Administration, Oral; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D009570:Nitriles; D011719:Pyrazines / Q000008:administration & dosage*; D011759:Pyrrolidines; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000008:administration & dosage*; D000077597:Vildagliptin
D000218:Adamantane; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D009570:Nitriles; D011719:Pyrazines; D011759:Pyrrolidines; D000068900:Sitagliptin Phosphate; D014230:Triazoles; D000077597:Vildagliptin